Study identifies a signaling mechanism linked to congenital heart defects — Evidence Review

Researchers at the University of Copenhagen have identified a previously unknown cell signaling mechanism in primary cilia that may help explain the origins of congenital heart defects. This discovery aligns with and extends earlier research highlighting the crucial role of cilia and cell signaling pathways in heart development, as supported by prior genetic and animal studies (6, 2, 4).

• The new study builds on earlier findings that cilia-related proteins and cilia-mediated signaling are important in congenital heart disease (CHD), corroborating genetic analyses in both human and animal models (2, 6).
• Related research has identified over 400 genes implicated in CHD, with several studies specifically recognizing the role of cilia and cilia-transduced signaling as central to pathogenesis (2, 6).
• Advances in cell and molecular biology, including single-cell analysis and stem cell technologies, are increasingly clarifying the complexity of cardiac development, supporting the notion that defects in cell signaling, particularly via cilia, can have widespread developmental consequences (4, 7).

Study Overview and Key Findings

Congenital heart disease remains one of the most common birth defects worldwide, yet the underlying biological mechanisms are incompletely understood. The new study from the University of Copenhagen addresses this gap by identifying a signaling mechanism within the primary cilium—a cellular structure often described as an "antenna"—that plays a crucial role in heart formation and, potentially, in the development of other organs. By integrating patient genetic data with experimental models, the researchers provide evidence that rare mutations affecting this ciliary signaling may underlie certain congenital heart defects, especially those that present alongside other organ abnormalities.

Property	Value
Study Year	2026
Organization	University of Copenhagen
Journal Name	PLOS Biology
Authors	Canan Doganli, Oskar Kaaber Thomsen, Daniel A. Baird, Yeasmeen Ali, Menachem V. K. Sarusie, Enrique Audain, Line Jeanett Jessen, Pauline Munck Truelsen, Johanne Bay Mogensen, Maria Schrøder Holm, Kateřina Apolínová, Lorenzo Buttò, Maria Diamanti, Jindřiška Leischner Fialová, Emma M. Wade, Stephen P. Robertson, Lotte Bang Pedersen, Laurent Argiro, Fabienne Lescroart, Marc-Phillip Hitz, Søren Tvorup Christensen, Lars Allan Larsen
Population	Patients with congenital heart defects, zebrafish, human cells, mouse stem
Methods	Animal Study
Outcome	Genetic mutations affecting heart development and ciliary function
Results	Identified a signaling mechanism linked to congenital heart defects.

Literature Review: Related Studies

To place these findings in context, we searched the Consensus database, which includes over 200 million research papers, using targeted queries about congenital heart defects and cell signaling. The following search queries were used:

1. congenital heart defects signaling mechanisms
2. cell signaling congenital heart abnormalities
3. genetic factors congenital heart defect risks

Below, we organize the major themes emerging from related studies and key findings for each:

Topic	Key Findings
What is the role of cell signaling and cilia in congenital heart defects?	- Cilia and cilia-mediated signaling pathways are central to the pathogenesis of congenital heart disease, with genetic mutations in ciliary genes implicated in both animal models and human patients (2, 6). - Cilia-related proteins and cilia-transduced signaling regulate heart morphogenesis and defects in these pathways can lead to syndromic conditions affecting multiple organs, not just the heart (2, 6, 4).
How do genetic and non-genetic factors contribute to CHD?	- Over 400 genes, including those involved in chromatin modification, cell signaling, and cilia function, have been associated with CHD, and both monogenic and complex genetic mechanisms have been identified (2, 9, 11). - Non-genetic factors, such as maternal health and environmental exposures, also play important but distinct roles in CHD risk (10, 12).
What are the latest advances in understanding cardiac development and CHD mechanisms?	- Advancements in stem cell technology, sequencing, and single-cell analysis have provided deeper insights into the molecular pathways governing heart development, including Wnt, Notch, retinoic acid, and others (4, 3, 8). - Cell-type specific regulatory elements and signaling pathways, such as Slit-Robo and Notch, are increasingly recognized as crucial in cardiac development (5, 7, 8).
How do defects in signaling pathways manifest in clinical and syndromic presentations?	- Disruption of cilia or signaling pathways during development can result in both isolated and syndromic congenital heart defects, with multiple organs potentially affected (2, 6, 4). - Clinical genetic testing and molecular diagnostics are improving identification of at-risk patients and understanding of disease mechanisms (11, 9).

What is the role of cell signaling and cilia in congenital heart defects?

The new study's emphasis on primary cilium signaling and its impact on cardiac development is well-supported by earlier research identifying cilia and associated pathways as fundamental to the pathogenesis of congenital heart defects. Large-scale genetic screens in mice and analyses in human populations have shown that mutations in cilia-related genes can disrupt heart formation and often result in broader syndromic conditions affecting multiple organ systems (2, 6, 4). The identification of TAK1, TAB2, and PKA-Cα as a ciliary signaling center offers a more precise mechanistic link and extends prior work by specifying molecular components.

• Cilia are essential for interpreting extracellular signals that instruct heart development, and their dysfunction is now a recognized cause of both isolated and syndromic CHDs (2, 6).
• Mutations in cilia-related genes disrupt not just the heart, but can also result in defects in the brain, kidneys, and skeleton (2, 4).
• The new study's use of patient data and animal models to demonstrate causality strengthens the evidence for this mechanistic link (6).
• Prior studies suggest that cilia-transduced signaling is a unifying explanation for diverse congenital malformations, consistent with the findings of the new research (2, 4, 6).

How do genetic and non-genetic factors contribute to CHD?

While the new study focuses on genetic mutations affecting ciliary signaling, the broader literature emphasizes both genetic diversity and the interplay with environmental factors in CHD risk. Genetic studies have cataloged hundreds of genes, including many involved in signaling and ciliary function, and highlight the complexity of both monogenic and multifactorial inheritance patterns (2, 9, 11). Non-genetic factors—such as maternal health, medication use, and environmental exposures—are also established contributors, though they typically act through different biological pathways (10, 12).

• Over 400 genes are implicated in CHD, many of which are involved in cell signaling and ciliary functions (2, 9).
• Both single-gene mutations and complex genetic interactions underlie different forms of CHD (11).
• Non-genetic risk factors, including maternal obesity, diabetes, medication exposures, and environmental chemicals, can increase the risk of CHD (10, 12).
• The interplay between genetic susceptibility and environmental exposures is a continuing area of research, particularly in understanding preventable risk factors (10, 12).

What are the latest advances in understanding cardiac development and CHD mechanisms?

Advances in molecular and cellular biology, especially through stem cell models and single-cell sequencing, are illuminating the complex regulatory networks that govern heart formation. Multiple signaling pathways—including Wnt, Notch, retinoic acid, and others—are now recognized as central to these processes (4, 3, 8). The identification of specific regulatory elements and non-coding mutations adds further nuance to the genetic architecture of heart development (7). The new study contributes by pinpointing a specific ciliary signaling mechanism as a key regulator, providing a more detailed map of the molecular events underlying CHD.

• Use of pluripotent stem cells and cardiac organoids allows for detailed dissection of developmental mechanisms (4).
• Single-cell analyses reveal the diversity of cardiac cell types and the regulatory elements that control their differentiation (7).
• Pathways like Wnt, Notch, and retinoic acid are well-established as essential for cardiac morphogenesis and are often disrupted in CHD (4, 3, 8).
• The new study's identification of TAK1, TAB2, and PKA-Cα as ciliary signaling proteins adds to this list of critical molecular players (4, 2).

How do defects in signaling pathways manifest in clinical and syndromic presentations?

Disruptions in signaling pathways, particularly those involving cilia, can lead to a spectrum of congenital heart defects, ranging from isolated cardiac malformations to syndromic presentations involving multiple organs. Clinical genetic testing is increasingly able to identify mutations underlying these conditions, aiding in early diagnosis and management (11, 9). The new study's observation that the same ciliary mechanism affects other organs aligns with clinical experiences of syndromic CHD and reinforces the importance of integrated molecular diagnostics.

• Many CHDs present as part of broader syndromes, with defects in brain, kidneys, or skeleton, often traceable to shared developmental pathways (2, 6, 4).
• Advances in genetic testing and sequencing technologies facilitate earlier and more precise identification of at-risk individuals (11, 9).
• Understanding the molecular basis of syndromic presentations may inform targeted therapies and prevention strategies (4, 9).
• The new study's findings support the concept of a shared developmental mechanism underlying multiple organ defects in syndromic CHD (2, 6, 4).

Future Research Questions

While this study significantly advances understanding of the molecular mechanisms underlying congenital heart defects, many questions remain. Further research is needed to clarify the full range of genes and signaling pathways involved, determine how environmental and genetic factors interact, and explore potential therapeutic strategies for affected individuals.

Research Question	Relevance
What other genes or proteins interact with the TAK1, TAB2, and PKA-Cα signaling axis in cardiac development?	Identifying additional interacting partners may reveal further components of the ciliary signaling network and potential therapeutic targets (2, 4, 6).
Can modulation of ciliary signaling pathways prevent or ameliorate congenital heart defects in model organisms or humans?	Testing whether interventions targeting ciliary signaling can affect outcomes will inform prevention or treatment strategies for CHD (2, 4).
How do environmental factors influence ciliary signaling and congenital heart defect risk?	Understanding gene-environment interactions could help identify modifiable risk factors and inform prevention efforts (10, 12).
What is the mechanism by which ciliary signaling defects affect multiple organ systems?	Exploring how ciliary signaling coordinates development across tissues will clarify why some mutations cause syndromic disease (2, 4, 6).
Can early genetic screening for ciliary signaling mutations improve diagnosis and clinical management of congenital heart defects?	Assessing the utility of genetic screening could lead to earlier detection and more personalized care for affected individuals (9, 11).